Peptide therapy claims on TikTok: what the science actually supports

What's this video probably claiming?

Creators in the peptide space on TikTok typically run a familiar playbook: BPC-157 heals your gut and tendons, TB-500 accelerates recovery like nothing else, CJC-1295 plus ipamorelin stacks will spike your growth hormone naturally, and GHK-Cu reverses skin aging at the cellular level. MK-677 often gets bundled in as a "safer" alternative to injectable growth hormone, while Semax and Selank get positioned as nootropic anxiety-killers with no downside profile. The framing is usually that these compounds are what doctors don't want you to know about, or that they work better than pharmaceuticals but without the risks. Given the account handle and category, this video almost certainly promotes one or more of these compounds with recovery, anti-aging, or cognitive enhancement claims, likely without distinguishing between animal data and human clinical evidence.

What does the science actually show?

The honest answer is: it depends heavily on the compound, and almost nothing has strong human trial data. BPC-157 has interesting preclinical results. A 2018 review by Sikiric et al. in Current Pharmaceutical Design documented accelerated wound healing and gastric mucosal repair in rodent models, but zero completed randomized controlled trials in humans exist as of 2024. TB-500 (Thymosin Beta-4) has one small Phase II trial in cardiac patients (Goldstein et al., 2012, Annals of the New York Academy of Sciences) showing modest signals, not the dramatic recovery results TikTok describes. CJC-1295 does increase IGF-1 levels in humans. Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism) showed a 2-3 fold increase in IGF-1 at doses of 30-60 mcg/kg, but sustained supraphysiological IGF-1 carries its own risk profile that creators routinely omit. MK-677 increases GH pulse amplitude but also raises fasting glucose and causes significant water retention, per Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism).

Where does the social media noise diverge from clinical reality?

The gap is significant in several ways. First, most peptide claims are extrapolated from rat studies at doses that don't translate cleanly to human physiology. Second, the "no side effects" narrative is not supported by evidence. Elevated IGF-1 from GHRH analogs like CJC-1295 is associated with increased cancer cell proliferation risk in vitro (Holly et al., 2006, Endocrine-Related Cancer). MK-677 is not a peptide at all, it is a ghrelin mimetic small molecule, and creators routinely misclassify it. Third, the compounded versions of these peptides sold through grey-market sources have no standardized purity verification. FDA warning letters issued in 2023 and 2024 targeted multiple peptide compounders for sterility failures and mislabeled concentrations. Semax and Selank have legitimate Russian clinical trial data for cognitive and anxiolytic effects, but that research is not replicated in Western peer-reviewed settings and the effect sizes are modest at best.

What should you actually know?

Peptides are not inherently snake oil, but they are also not the risk-free biohacking tools TikTok makes them out to be. Some compounds, like GHK-Cu in topical form, have reasonable safety profiles and some peer-reviewed cosmetic research behind them (Pickart et al., 2015, Journal of Aging Research). Others, like injectable BPC-157 in humans, have no approved indication anywhere in the world and no safety data from controlled human trials. The FDA has classified several of these peptides as not eligible for compounding under 503A and 503B frameworks. If a provider is prescribing these without discussing the evidentiary limitations, that is a red flag. Stacking multiple peptides, which TikTok creators often suggest, compounds the unknown risk profile multiplicatively. Anyone considering peptide therapy should have that conversation with a licensed clinician who can explain what we actually know versus what is being inferred from animal models.